Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2012 Feb 2;20(2):469. doi: 10.1038/mt.2011.240

Corrigendum to “Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects”

PMCID: PMC3277232  PMID: 28157525

Evangelia Yannaki, Thalia Papayannopoulou, Erica Jonlin, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, Pamela Becker, Nikoleta Psatha, Ioannis Batsis, Panayotis Kaloyannidis, Varvara Tahynopoulou, Varnavas Constantinou, Asimina Bouinta, Konstantia Kotta, Aglaia Athanassiadou, Achilles Anagnostopoulos, Athanasios Fassas and George Stamatoyannopoulos

Molecular Therapy (2012); 20: 230–238. doi:10.1038/mt.2011.195

Following the online publication of this article, the authors noted errors in Figure 2. The corrected figure appears below:

Figure 2.

Figure 2


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES